S20G mutation of the amylin gene is associated with a lower body mass index in Korean type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 60, Issue 2, 2003, Pages 125-129

  Cho, Young Min ^a,b   Kim, Min ^b   Park, Kyong Soo ^a,b   Kim, Seong Yeon ^a   Lee, Hong Kyu ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Amylin; Body mass index; Mutation; Type 2 diabetes

Indexed keywords

AMYLIN; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; STATISTICAL SIGNIFICANCE; WILD TYPE;

EID: 0037405423     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(03)00019-6     Document Type: Article

References (17)

1. Taylor S.I., Accili D., Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM. Diabetes. 43:1994;735-740.
2. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 15:1992;318-368.
3. Ghosh S., Schork N.J. Genetic analysis of NIDDM. The study of quantitative traits. Diabetes. 45:1996;1-14.
4. Westermark P. Amyloid and polypeptide hormones: what is their relationship. Amyloid. 1:1994;47-60.
5. Cooper G.J., Willis A.C., Clark A., Turner R.C., Sim R.B., Reid K.B. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA. 84:1987;8628-8632.
6. Sanke T., Hanabusa T., Nakano Y., et al. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 34:1991;129-132.
7. Mosselman S., Höppener J.W., de Wit L., Soeller W., Lips C.J., Jansz H.S. IAPP/amylin gene transcriptional control region: evidence for negative regulation. FEBS Lett. 271:1990;33-36.
8. German M.S., Moss L.G., Wang J., Rutter W.J. The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes. Mol. Cell Biol. 12:1992;1777-1788.
9. Höppener J.W., Ahren B., Lips C.J. Islet amyloid and type 2 diabetes mellitus. N. Engl. J. Med. 343:2000;411-419.
10. Lorenzo A., Razzaboni B., Weir G.C., Yankner B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 368:1994;756-760.
11. Sakagashira S., Sanke T., Hanabusa T., et al. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes. 45:1996;1279-1281.
12. Seino S. S20G mutation of the amylin gene is associated with Type II diabetes in Japanese. Diabetologia. 44:2001;906-909.
13. Sakagashira S., Hiddinga H.J., Tateishi K., et al. S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am. J. Pathol. 157:2000;2101-2109.
14. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
15. Chuang L.M., Lee K.C., Huang C.N., Wu H.P., Tai T.Y., Lin B.J. Role of S20G mutation of amylin gene in insulin secretion, insulin sensitivity, and type II diabetes mellitus in Taiwanese patients. Diabetologia. 41:1998;1250-1251.
16. Lee S.C., Hashim Y., Li J.K., et al. The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels. Clin. Endocrinol. (Oxford). 54:2001;541-546.
17. Hayakawa T., Nagai Y., Ando H., et al. S20G mutation of the amylin gene in Japanese patients with type 2 diabetes. Diabetes Res. Clin. Pract. 49:2000;195-197.